Literature DB >> 21875960

Necessary and sufficient role for T helper cells to prevent fungal dissemination in allergic lung disease.

Paul C Porter1, Luz Roberts, Anna Fields, Morgan Knight, Yuping Qian, George L Delclos, Shuhua Han, Farrah Kheradmand, David B Corry.   

Abstract

Mucosal immune responses to fungal infection range from T helper type 2 (Th2) cell-directed allergic inflammation to Th1-predominant neutrophilic inflammation, but the mechanisms directing these divergent mucosal immune outcomes and the role of T cells in host defense against mucosal fungal infections are not known. Here we examined the mouse mucosal immune responses to 12 filamentous environmental fungal species over a broad range of exposure doses and determined the requirement of T cells for host defense. For all tested fungi, low-grade conidium exposures induced Th2- and eosinophil-predominant allergic lung disease, whereas higher exposures led to rapid conversion to neutrophil- and Th1 cell-predominant inflammation, a phenomenon we term immune phenotype switching. All fungal exposure doses were further linked to the secretion of interleukin-17A (IL-17A). Fungal infections with Curvularia lunata and Aspergillus fumigatus were typically confined to the airway during allergic inflammation but became locally invasive and disseminated to the brain at higher conidium challenge doses, in association with predominant Th1 responses. Fungal dissemination occurred at relatively low challenge doses with the conidia of Aspergillus fumigatus administered to recombinase activating gene 1 (Rag-1)-deficient mice, which lack B and T cells, but B cell-deficient μMT mice and T helper cell-reconstituted Rag-1-deficient mice were comparable to wild-type mice in preventing fungal dissemination. Our findings demonstrate that Th2 cell-predominant allergic responses followed by immune phenotype switching and fungal dissemination are highly predictable outcomes with progressive fungal infectious burdens and that T helper cell responses are protective against lethal fungal dissemination.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21875960      PMCID: PMC3257943          DOI: 10.1128/IAI.05209-11

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  58 in total

Review 1.  The burden of asthma with specific reference to the United States.

Authors:  Richard Beasley
Journal:  J Allergy Clin Immunol       Date:  2002-05       Impact factor: 10.793

Review 2.  The clinical spectrum of pulmonary aspergillosis.

Authors:  Ayman O Soubani; Pranatharthi H Chandrasekar
Journal:  Chest       Date:  2002-06       Impact factor: 9.410

3.  Interleukin-4 causes susceptibility to invasive pulmonary aspergillosis through suppression of protective type I responses.

Authors:  E Cenci; A Mencacci; G Del Sero; A Bacci; C Montagnoli; C F d'Ostiani; P Mosci; M Bachmann; F Bistoni; M Kopf; L Romani
Journal:  J Infect Dis       Date:  1999-12       Impact factor: 5.226

Review 4.  Diagnosis and treatment of allergic bronchopulmonary aspergillosis.

Authors:  N E Vlahakis; T R Aksamit
Journal:  Mayo Clin Proc       Date:  2001-09       Impact factor: 7.616

5.  Chronic airway hyperreactivity, goblet cell hyperplasia, and peribronchial fibrosis during allergic airway disease induced by Aspergillus fumigatus.

Authors:  C M Hogaboam; K Blease; B Mehrad; M L Steinhauser; T J Standiford; S L Kunkel; N W Lukacs
Journal:  Am J Pathol       Date:  2000-02       Impact factor: 4.307

Review 6.  Diagnostic features and differential diagnosis of Churg-Strauss syndrome in the lung. A review.

Authors:  A L Katzenstein
Journal:  Am J Clin Pathol       Date:  2000-11       Impact factor: 2.493

7.  Activation of the alternative complement pathway by fungal melanins.

Authors:  A L Rosas; R S MacGill; J D Nosanchuk; T R Kozel; A Casadevall
Journal:  Clin Diagn Lab Immunol       Date:  2002-01

Review 8.  Respiratory tract allergic disease and atopy: experimental evidence for a fungal infectious etiology.

Authors:  Paul Porter; Sumanth Polikepahad; Yuping Qian; J Morgan Knight; Wen Lu; Wendy M-T Tai; Luz Roberts; Valentine Ongeri; Tianshu Yang; Alexander Seryshev; Stuart Abramson; George L Delclos; Farrah Kheradmand; David B Corry
Journal:  Med Mycol       Date:  2010-08-31       Impact factor: 4.076

Review 9.  Airway inflammation and remodeling in asthma.

Authors:  J V Fahy; D B Corry; H A Boushey
Journal:  Curr Opin Pulm Med       Date:  2000-01       Impact factor: 3.155

10.  Deep dermatophytoses in association with atopy and diabetes mellitus: Majocchi's granuloma tricophyticum or dermatophytic pseudomycetoma?

Authors:  Zülal Erbağci
Journal:  Mycopathologia       Date:  2002       Impact factor: 2.574

View more
  23 in total

1.  High prevalence of asthma in HIV-infected adults: new insights.

Authors:  William T Shearer; David B Corry
Journal:  J Allergy Clin Immunol       Date:  2012-01-31       Impact factor: 10.793

Review 2.  Fungi in Mucoobstructive Airway Diseases.

Authors:  Evan Li; Cameron T Landers; Hui-Ying Tung; J Morgan Knight; Zachary Marshall; Amber U Luong; Antony Rodriguez; Farrah Kheradmand; David B Corry
Journal:  Ann Am Thorac Soc       Date:  2018-11

3.  Host response to pulmonary fungal infections: A highlight on cell-driven immunity to Cryptococcus species and Aspergillus fumigatus.

Authors:  Orchi Dutta; Jorge A Masso-Silva; Keyi Wang; Amariliz Rivera
Journal:  Curr Pharmacol Rep       Date:  2017-10-14

4.  Airway surface mycosis in chronic TH2-associated airway disease.

Authors:  Paul C Porter; Dae Jun Lim; Zahida Khan Maskatia; Garbo Mak; Chu-Lin Tsai; Martin J Citardi; Samer Fakhri; Joanne L Shaw; Annette Fothergil; Farrah Kheradmand; David B Corry; Amber Luong
Journal:  J Allergy Clin Immunol       Date:  2014-06-11       Impact factor: 10.793

Review 5.  An Update on Lymphocyte Subtypes in Asthma and Airway Disease.

Authors:  Daniel M Moldaver; Mark Larché; Christopher D Rudulier
Journal:  Chest       Date:  2016-11-03       Impact factor: 9.410

Review 6.  Airway fibrinogenolysis and the initiation of allergic inflammation.

Authors:  Valentine Ongeri Millien; Wen Lu; Garbo Mak; Xiaoyi Yuan; J Morgan Knight; Paul Porter; Farrah Kheradmand; David B Corry
Journal:  Ann Am Thorac Soc       Date:  2014-12

7.  The immunology of asthma.

Authors:  Bart N Lambrecht; Hamida Hammad
Journal:  Nat Immunol       Date:  2015-01       Impact factor: 25.606

8.  Selective cleavage of fibrinogen by diverse proteinases initiates innate allergic and antifungal immunity through CD11b.

Authors:  Cameron T Landers; Hui-Ying Tung; J Morgan Knight; Matthew C Madison; Yifan Wu; Zhimin Zeng; Paul C Porter; Antony Rodriguez; Matthew J Flick; Farrah Kheradmand; David B Corry
Journal:  J Biol Chem       Date:  2019-04-16       Impact factor: 5.157

Review 9.  Tracheobronchial mycosis in a retrospective case-series study of five status asthmaticus patients.

Authors:  Garbo Mak; Paul C Porter; Venkata Bandi; Farrah Kheradmand; David B Corry
Journal:  Clin Immunol       Date:  2012-11-27       Impact factor: 3.969

10.  CD11a polymorphisms regulate TH2 cell homing and TH2-related disease.

Authors:  John M Knight; Seung-Hyo Lee; Luz Roberts; C Wayne Smith; Scott T Weiss; Farrah Kheradmand; David B Corry
Journal:  J Allergy Clin Immunol       Date:  2013-05-29       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.